Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions

Lindsey Anderson, Charles Tapley Hoyt, Jeremy Zucker, Andrew McNaughton, Jeremy Teuton, Klas Karis, Natasha N. Arokium-Christian, Jackson T. Warley, Zachary R. Stromberg, Benjamin M. Gyori, Neeraj Kumar

Abstract

The development of effective vaccines is crucial for combating current and emerging pathogens. Despite significant advances, challenges remain, including the lack of standardized data reporting and curation practices, which complicates the determination of correlates of protection. This review explores the current landscape of vaccine development, highlighting computational challenges and opportunities for leveraging artificial intelligence (AI) and machine learning (ML) through the integration of diverse data types. We discuss the roles of natural language processing (NLP), semantic integration, and causal inference in extracting insights from unstructured sources and modeling immune responses. Emphasizing the need for standardized formats and ontologies, we argue that data harmonization is key to accelerating the development of safe and effective vaccines.

Introduction: From Empirical to Rational Design

Traditional vaccine development has historically relied on empirical "trial-and-error" methods, which are often slow and expensive. While the rapid response to COVID-19 demonstrated the potential for speed, consistently addressing rapidly mutating pathogens like HIV or influenza requires a transition to "rational" design. This shift depends on a deep understanding of the complex interplay between pathogens and the host immune system.

The primary obstacle to this transition is not a lack of data, but a lack of integration. Critical vaccine information is currently siloed in unstructured journal text, proprietary registries, and inconsistent databases. Without standardized reporting, it is difficult for machine learning models to identify correlates of protection (CoPs) or learn from "negative data"—the valuable lessons from failed vaccine candidates.

Computational Strategies for Data Integration

To overcome these fragmentation issues, researchers are deploying a suite of advanced computational strategies aimed at creating a unified, machine-ready knowledge ecosystem.

Conceptual framework for integrating vaccine and pathogen data through enabling technologies and computational methods to improve vaccine development.

Key strategies include:

  • Semantic Integration and Ontologies: Structured frameworks like the Vaccine Ontology (VO) and Chemical Entities of Biological Interest (ChEBI) provide unique, machine-readable identifiers for biological entities, such as adjuvants and antigens.
  • Natural Language Processing (NLP): Transformer-based models (e.g., PubMedBERT, BioBERT) and Large Language Models (LLMs) are used for Named Entity Recognition (NER) and Relation Extraction, turning millions of research papers into structured data.
  • Knowledge Graphs: By encoding relationships between vaccines, pathogens, and hosts as semantic triples (subject-predicate-object), researchers can enable large-scale automated reasoning.
  • Causal Inference and Uncertainty Quantification (UQ): These methods move beyond simple correlation to understand the mechanisms of vaccine efficacy while defining the reliability boundaries of AI models—a critical requirement for clinical safety.

The Vaccine Data Landscape

A comprehensive map of the vaccine data landscape involves harmonizing various sources:

  • Clinical Registries: Platforms like ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) provide essential trial data.
  • Curated Databases: Specialized resources such as VIOLIN (Vaccine Investigation and Online Information Network) and the Immune Epitope Database (IEDB) offer high-quality, manually curated information.
  • Standardized Frameworks: The PICO (Population, Intervention, Comparison, Outcome) framework is increasingly emphasized for harmonizing clinical trial results across different studies.

Challenges and Future Directions

Despite the promise of AI-assisted design, several hurdles remain. The "negative data" void—the lack of detailed publications on failed trials—creates selection bias in ML models. Furthermore, metadata gaps regarding specific adjuvant formulations or dosing schedules hinder the replication and aggregation of findings.

While LLMs offer powerful data extraction capabilities, concerns regarding "hallucinations" and the difficulty of tracing generated responses back to primary evidence persist. Additionally, the increasing complexity of next-generation platforms (e.g., mRNA, engineered nanoparticles) challenges the limits of current ontologies.

Looking forward, the NIH 2023 data sharing policy is expected to be a major catalyst for making raw data publicly available. Realizing the full potential of AI in vaccinology will require sustained interdisciplinary collaboration between data scientists, immunologists, and public health experts to build integrated knowledge bases that combine clinical trial data with real-world evidence.

Summary updated

Abstract

The development of effective vaccines is crucial for combating current and emerging pathogens. Despite significant advances in the field of vaccine development there remain numerous challenges including the lack of standardized data reporting and curation practices, making it difficult to determine correlates of protection from experimental and clinical studies. Significant gaps in data and knowledge integration can hinder vaccine development which relies on a comprehensive understanding of the interplay between pathogens and the host immune system. In this review, we explore the current landscape of vaccine development, highlighting the computational challenges, limitations, and opportunities associated with integrating diverse data types for leveraging artificial intelligence (AI) and machine learning (ML) techniques in vaccine design. We discuss the role of natural language processing, semantic integration, and causal inference in extracting valuable insights from published literature and unstructured data sources, as well as the computational modeling of immune responses. Furthermore, we highlight specific challenges associated with uncertainty quantification in vaccine development and emphasize the importance of establishing standardized data formats and ontologies to facilitate the integration and analysis of heterogeneous data. Through data harmonization and integration, the development of safe and effective vaccines can be accelerated to improve public health outcomes. Looking to the future, we highlight the need for collaborative efforts among researchers, data scientists, and public health experts to realize the full potential of AI-assisted vaccine design and streamline the vaccine development process.
BibTeX
@inproceedings{anderson2025computational,
  author = {Lindsey Anderson and Charles Tapley Hoyt and Jeremy Zucker and Andrew McNaughton and Jeremy Teuton and Klas Karis and Natasha N. Arokium-Christian and Jackson T. Warley and Zachary R. Stromberg and Benjamin M. Gyori and Neeraj Kumar},
  title = {{Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1502484},
}
Figure